| |
| |
|
| Insider
Information: |
Miller Marvin |
| Relationship: |
Director |
| City: |
Framingham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
128,595 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$38 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
128,595 |
|
|
| Total
Value |
$38 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
GTC Biotherapeutics Inc |
GTCB |
Director |
2009-09-25 |
3,585 |
2004-05-11 |
0 |
Premium* |
|
|
Unigene Laboratories Inc |
UGNEQ |
Director |
2011-07-06 |
125,010 |
2006-06-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| UGNEQ |
Unigene Laboratories Inc |
Director |
– • – |
2011-07-06 |
4 |
A |
$1.04 |
$12,000 |
D/D |
11,538 |
125,010 |
0 |
- |
|
| UGNEQ |
Unigene Laboratories Inc |
Director |
– • – |
2011-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
113,472 |
0 |
- |
|
| UGNEQ |
Unigene Laboratories Inc |
Director |
– • – |
2011-01-05 |
4 |
A |
$0.78 |
$12,000 |
D/D |
15,385 |
103,472 |
0 |
- |
|
| UGNEQ |
Unigene Laboratories Inc |
Director |
– • – |
2010-07-06 |
4 |
A |
$0.76 |
$12,000 |
D/D |
15,789 |
88,087 |
0 |
- |
|
| UGNEQ |
Unigene Laboratories Inc |
Director |
– • – |
2010-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
72,298 |
0 |
- |
|
| UGNEQ |
Unigene Laboratories Inc |
Director |
– • – |
2010-01-06 |
4 |
A |
$0.72 |
$12,000 |
D/D |
16,667 |
42,298 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • – |
2009-09-25 |
4 |
A |
$1.76 |
$1,201 |
D/D |
683 |
3,585 |
0 |
- |
|
| UGNEQ |
Unigene Laboratories Inc |
Director |
– • – |
2009-07-06 |
4 |
A |
$1.40 |
$6,000 |
D/D |
4,286 |
25,631 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • – |
2009-06-26 |
4 |
A |
$2.70 |
$1,199 |
D/D |
444 |
2,902 |
0 |
- |
|
| UGNEQ |
Unigene Laboratories Inc |
Director |
– • – |
2009-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
21,345 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • – |
2009-03-27 |
4 |
A |
$0.33 |
$1,200 |
D/D |
3,636 |
24,584 |
0 |
- |
|
| UGNEQ |
Unigene Laboratories Inc |
Director |
– • – |
2009-01-06 |
4 |
A |
$0.58 |
$6,000 |
D/D |
10,345 |
10,345 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • – |
2008-12-26 |
4 |
A |
$0.28 |
$1,200 |
D/D |
4,309 |
20,948 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • – |
2008-09-26 |
4 |
A |
$0.37 |
$1,200 |
D/D |
3,243 |
16,639 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • – |
2008-06-27 |
4 |
A |
$0.40 |
$1,200 |
D/D |
2,985 |
13,396 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • – |
2008-03-28 |
4 |
A |
$0.55 |
$1,200 |
D/D |
2,182 |
10,411 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • – |
2007-12-28 |
4 |
A |
$0.87 |
$1,200 |
D/D |
1,379 |
8,229 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • – |
2007-09-28 |
4 |
A |
$1.02 |
$1,200 |
D/D |
1,176 |
6,850 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • – |
2007-06-29 |
4 |
A |
$1.15 |
$1,199 |
D/D |
1,043 |
5,674 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • – |
2007-03-30 |
4 |
A |
$1.02 |
$800 |
D/D |
781 |
4,631 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • – |
2006-12-29 |
4 |
A |
$1.11 |
$800 |
D/D |
721 |
3,850 |
0 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • – |
2006-09-29 |
4 |
A |
$1.24 |
$1,400 |
D/D |
1,129 |
3,129 |
0 |
- |
|
| UGNEQ |
Unigene Laboratories Inc |
Director |
– • – |
2006-06-12 |
4 |
B |
$3.46 |
$3,460 |
D/D |
1,000 |
1,000 |
2.31 |
- |
|
| GTCB |
GTC Biotherapeutics Inc |
Director |
– • – |
2004-05-11 |
4 |
A |
$1.83 |
$3,669 |
D/D |
2,000 |
2,000 |
|
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
